BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35091808)

  • 1. Bladder carcinomas in patients with neurogenic bladder and urinary schistosomiasis: are they the same tumors?
    Cancrini F; Michel F; Cussenot O; Alshehhi H; Comperat E; Phé V
    World J Urol; 2022 Aug; 40(8):1949-1959. PubMed ID: 35091808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of the immunohistochemical profile of bladder cancer in neuro-urological patients by the French Association of Urology.
    Michel F; Cancrini F; Cancel-Tassin G; Gamé X; Huyghe E; Rock A; Léon G; Uzan A; Desfemmes FR; Peyronnet B; Fallot J; Léon P; Rolland E; Perrouin-Verbe MA; Wodey J; Capon G; Karsenty G; Rouprêt M; Cussenot O; Alshehhi H; Comperat E; Phé V
    World J Urol; 2022 Aug; 40(8):1939-1947. PubMed ID: 35138436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD10 and E-cad expression in urinary bladder urothelial and squamous cell carcinoma.
    Omran OM
    J Environ Pathol Toxicol Oncol; 2012; 31(3):203-12. PubMed ID: 23339695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the p53 gene in schistosomal bladder cancer: a study of 92 tumours from Egyptian patients and a comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumours.
    Warren W; Biggs PJ; el-Baz M; Ghoneim MA; Stratton MR; Venitt S
    Carcinogenesis; 1995 May; 16(5):1181-9. PubMed ID: 7767983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of variants of urothelial carcinoma of the urinary bladder.
    Paner GP; Annaiah C; Gulmann C; Rao P; Ro JY; Hansel DE; Shen SS; Lopez-Beltran A; Aron M; Luthringer DJ; De Peralta-Venturina M; Cho Y; Amin MB
    Hum Pathol; 2014 Jul; 45(7):1473-82. PubMed ID: 24780825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A four-antibody immunohistochemical panel can distinguish clinico-pathological clusters of urothelial carcinoma and reveals high concordance between primary tumor and lymph node metastases.
    Bontoux C; Rialland T; Cussenot O; Compérat E
    Virchows Arch; 2021 Apr; 478(4):637-645. PubMed ID: 33128085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor markers of bladder cancer: the schistosomal bladder tumors versus non-schistosomal bladder tumors.
    Abdulamir AS; Hafidh RR; Kadhim HS; Abubakar F
    J Exp Clin Cancer Res; 2009 Feb; 28(1):27. PubMed ID: 19243595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems.
    Oliva E; Amin MB; Jimenez R; Young RH
    Am J Surg Pathol; 2002 Feb; 26(2):190-7. PubMed ID: 11812940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: bladder carcinomas in patients with neurogenic bladder and urinary schistosomiasis-are they the same tumors?
    Wishahi M; Otto T; Golka K
    World J Urol; 2022 Aug; 40(8):2139-2140. PubMed ID: 35780403
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterisation of tumour-immune phenotypes and PD-L1 positivity in squamous bladder cancer.
    Jung M; Rose M; Knuechel R; Loeffler C; Muti H; Kather JN; Gaisa NT;
    BMC Cancer; 2023 Feb; 23(1):113. PubMed ID: 36726072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications.
    Logani S; Oliva E; Amin MB; Folpe AL; Cohen C; Young RH
    Am J Surg Pathol; 2003 Nov; 27(11):1434-41. PubMed ID: 14576476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokeratin 20, AN43, PGDH, and COX-2 expression in transitional and squamous cell carcinoma of the bladder.
    Gee JR; Montoya RG; Khaled HM; Sabichi AL; Grossman HB
    Urol Oncol; 2003; 21(4):266-70. PubMed ID: 12954496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urothelial carcinoma with prominent squamous differentiation in the setting of neurogenic bladder: role of human papillomavirus infection.
    Blochin EB; Park KJ; Tickoo SK; Reuter VE; Al-Ahmadie H
    Mod Pathol; 2012 Nov; 25(11):1534-42. PubMed ID: 22766788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review and meta-analysis of CK20, CD44, Ki67 and p53 as immunohistochemical markers in bladder carcinoma in situ.
    Straccia P; Fiorentino V; Martini M; Pierconti F
    Actas Urol Esp (Engl Ed); 2022 Nov; 46(9):521-530. PubMed ID: 36216762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of bcl-2 and p53 oncoproteins in schistosomiasis-associated transitional and squamous cell carcinoma of urinary bladder.
    Chaudhary KS; Lu QL; Abel PD; Khandan-Nia N; Shoma AM; el Baz M; Stamp GW; Lalani EN
    Br J Urol; 1997 Jan; 79(1):78-84. PubMed ID: 9043502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic stratification of muscle invasive urothelial carcinomas using limited immunohistochemical panel of Gata3 and cytokeratins 5/6, 14 and 20.
    Jangir H; Nambirajan A; Seth A; Sahoo RK; Dinda AK; Nayak B; Kaushal S
    Ann Diagn Pathol; 2019 Dec; 43():151397. PubMed ID: 31494492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA copy number changes in Schistosoma-associated and non-Schistosoma-associated bladder cancer.
    El-Rifai W; Kamel D; Larramendy ML; Shoman S; Gad Y; Baithun S; El-Awady M; Eissa S; Khaled H; Soloneski S; Sheaff M; Knuutila S
    Am J Pathol; 2000 Mar; 156(3):871-8. PubMed ID: 10702404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of loss of heterozygosity on chromosomes 8 and 9 in the development and progression of cancer bladder.
    Abdel Wahab AH; Abo-Zeid HI; El-Husseini MI; Ismail M; El-Khor AM
    J Egypt Natl Canc Inst; 2005 Dec; 17(4):260-9. PubMed ID: 17102820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 protein and Ki-67 overexpression in urothelial dysplasia of bladder.
    Sun W; Zhang PL; Herrera GA
    Appl Immunohistochem Mol Morphol; 2002 Dec; 10(4):327-31. PubMed ID: 12607601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.